BackgroundSarcoptic mange has been identified as the most significant infectious disease affecting the Iberian ibex (Capra pyrenaica). Despite several studies on the effects of mange on ibex, the pathological and clinical picture derived from sarcoptic mange infestation is still poorly understood. To further knowledge of sarcoptic mange pathology, samples from ibex were evaluated from histological, microbiological and serological perspectives.MethodsSamples of skin, non-dermal tissues and blood were collected from 54 ibex (25 experimentally infected, 15 naturally infected and 14 healthy). Skin biopsies were examined at different stages of the disease for quantitative cellular, structural and vascular changes. Sixteen different non-dermal tissues of each ibex were taken for histological study. Acetylcholinesterase and serum amyloid A protein levels were evaluated from blood samples from ibex with different lesional grade. Samples of mangy skin, suppurative lesions and internal organs were characterized microbiologically by culture. Bacterial colonies were identified by a desorption/ionization time-of-flight mass spectrometry system (MALDI TOF/TOF).ResultsThe histological study of the skin lesions revealed serious acanthosis, hyperkeratosis, rete ridges, spongiotic oedema, serocellular and eosinophilic crusts, exocytosis foci, apoptotic cells and sebaceous gland hyperplasia. The cellular response in the dermis was consistent with type I and type IV hypersensitivity responses. The most prominent histological findings in non-dermal tissues were lymphoid hyperplasia, leukocytosis, congestion and the presence of amyloid deposits. The increase in serum concentrations of acetylcholinesterase and amyloid A protein correlated positively with the establishment of the inflammatory response in mangy skin and the presence of systemic amyloidosis. A wide variety of bacterial agents were isolated and the simultaneous presence of these in mangy skin, lymph nodes and internal organs such as lungs, liver, spleen and kidney was compatible with a septicaemic pattern of infection.ConclusionsThe alteration of biomarkers of inflammation and its implication in the pathogenesis of the disease and development of lesions in non-dermal tissues and septicaemic processes are serious conditioners for the survival of the mangy ibex. This severe clinical picture could be an important factor when considering the decision to eliminate animals that exceed a certain disease threshold from a population.

No abstract

No abstract

Sarcoptic mange is a contagious skin disease caused by Sarcoptes scabiei, affecting both domestic and wild mammals, including the Iberian ibex (Capra pyrenaica), a medium-sized mountain ungulate almost endemic to the Iberian Peninsula. Acute phase proteins (APPs) could be an indicator of sarcoptic mange disease and severity in Iberian ibex. Serum samples from 131 healthy and sarcoptic mange-affected Iberian ibexes were collected from 2005 to 2012 in Sierra Nevada Natural Space in southern Spain. Serum alpha-1-acid glycoprotein (AGP), serum amyloid A (SAA) and haptoglobin (Hp) concentrations were quantified, and statistically significant differences according to sarcoptic mange disease and severity were assessed. Both AGP and SAA were significantly higher in the sarcoptic mange-affected ibexes than in the healthy ones as well as in the severely affected ibexes as compared to those with less than 50 % of the body surface affected. For the first time, changes in APP are reported in relation to sarcoptic mange in Iberian ibex. It is also reported for the first time that the intensity of APP increase depends on the severity of sarcoptic mange, which could be related with the pathological secondary amyloidosis, leading to organ dysfunction in severely mange-affected animals. Species and population differences in the increase of APP in response to sarcoptic mange could indicate individual and population differences in the immune capability of each population to deal with mange, population prevalence and mortality being the last indicators of such sensitivity.

Sarcoptic mange is a cosmopolitan disease affecting the skin of domestic and wild mammalian species and humans as well. In Eurasia, sarcoptidosis (also known as sarcoptic mange or scabies) affects mountain ungulates (Caprinae) among other wild hosts, and epizootic outbreaks induce variable mortality rates. This fact, coupled with the important ecological and socio‐economic values of such mammalian hosts, resulted in many research projects being focused on addressing ecological, physiological, behavioural, genetic, and pathological effects of the disease. Nevertheless, information about management of sarcoptic mange in free‐ranging populations is scarce and scattered, with contradictory results and a lack of consensus on basic aspects of the disease. In this review, we summarise knowledge on the effects of sarcoptic mange in wild Caprinae, at individual, pathological and population epidemiological levels, as well as on the current tools and management strategies for its detection, diagnosis, prevention, and control. Disease spread in naïve populations is ca. 6 km year−1, and the mortality rate can be >95%. Tools for monitoring the disease include visual diagnosis, photographic traps, trained dogs, thermography, immunodiagnostics, molecular tools, radiocollars, and epidemiological modelling. Options for management include eradication, control, and prevention of the disease; biosecurity and prevention of spread to humans can be achieved by careful hygiene methods. Sarcoptic mange is a natural, biological factor controlling host population numbers and dynamics in Caprinae, so goals and strategies for its management in wild populations must be set accordingly. Specific management programmes for preventing and controlling sarcoptic mange in wild Caprinae populations must be based on reliable epidemiological data. More research is needed to provide evidence‐based policies. The efficacy and safety of various management approaches remain to be tested experimentally.